LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
13.95
+0.03 (0.22%)
At close: May 12, 2025, 4:00 PM
13.95
0.00 (0.00%)
After-hours: May 12, 2025, 4:00 PM EDT
LENSAR Market Cap
LENSAR has a market cap or net worth of $164.93 million as of May 12, 2025. Its market cap has increased by 343.99% in one year.
Market Cap
164.93M
Enterprise Value
141.34M
1-Year Change
343.99%
Ranking
Category
Stock Price
$13.95
Market Cap Chart
Since October 2, 2020, LENSAR's market cap has increased from $78.01M to $164.93M, an increase of 111.44%. That is a compound annual growth rate of 17.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 164.11M | 58.05% |
| Dec 31, 2024 | 103.84M | 163.00% |
| Dec 29, 2023 | 39.48M | 21.00% |
| Dec 30, 2022 | 32.63M | -50.28% |
| Dec 31, 2021 | 65.63M | -14.91% |
| Dec 31, 2020 | 77.13M | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |